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Sirtuins are NAD-dependent protein deacetylases that were shown to have protective
effects against different age-related diseases. SIRT2 is a strong deacetylase that is
highly expressed in brain. It has been associated with neurodegenerative diseases.
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a dopaminergic neurotoxin that
displays clinical features of Parkinson’s Disease (PD). MPTP leads to the degeneration
of nigrostriatal dopaminergic pathway after its systemic administration. Chronic
administration of MPTP induces lesion via apoptosis. We show here that SIRT2
deacetylates Foxo3a, increases RNA and protein levels of Bim, and as a result enhances
apoptosis in the MPTP model of PD. We also show that neurodegeneration induced by
chronic MPTP regimen is prevented by genetic deletion of SIRT2 in mouse. Deletion of
SIRT2 leads to the reduction of apoptosis due to an increase in acetylation of Foxo3a and
a decrease in Bim levels. We demonstrate that SIRT2 deacetylates Foxo3a, activates Bim,
and induces apoptosis only in MPP+-treated cells. Therefore, designing SIRT2 inhibitors
might be helpful in developing effective treatments for PD.
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INTRODUCTION
Parkinson’s Disease (PD), the most common movement dis-
order and the second most common neurodegenerative dis-
ease after Alzheimer’s disease, is characterized primarily by the
loss of dopaminergic neurons. MPTP is the most commonly
used dopaminergic neurotoxin that leads to the degeneration
of nigrostriatal dopaminergic pathway after its systemic admin-
istration. It is still the only PD model that displays repro-
ducible neurodegeneration. The chronic MPTP regimen leads
to neurodegeneration via apoptosis (Dauer and Przedborski,
2003).
Sirtuins are NAD-dependent protein deacetylases that were
shown to have protective effects against different age-related dis-
eases (Donmez and Guarente, 2010; Donmez, 2012). SIRT1 was
shown to reduce Abeta peptide formation in an Alzheimer’s dis-
ease mouse model and suppress alpha-synuclein aggregation in
A53T alpha-synuclein mouse model (Donmez et al., 2010, 2012).
SIRT2 is a strong protein deacetylase, and is highly expressed
in brain. It was shown to be an abundant neuronal protein
that accumulates in the central nervous system of aging mice
(Maxwell et al., 2011). SIRT2 was shown to co-localize with
microtubules and functions as alpha-tubulin deacetylase. During
G2/M phase, SIRT2 proteins enter nuclei and deacetylate histones
Abbreviations: TH, tyrosine hydroxylase; SNpc, substantia nigra pars compacta;
MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; SIRT2, Sirtuin2; KO, knock-
out.
(Donmez, 2012). A recent study showed that SIRT2 inhibitors
protected against dopaminergic cell death both in vitro and in
a Drosophila model of PD (Outerio et al., 2007). In addition,
SIRT2 inhibition was shown to protect against Huntington’s dis-
ease by reducing sterol biosynthesis (Luthi-Carter et al., 2010).
SIRT2 expression was also shown to increase in cells with oxida-
tive stress, such as hydrogen peroxide treatment and SIRT2 was
shown to promote cell death when cells are under severe stress
by activating Bim, a proapoptotic factor (Wang et al., 2007).
However, the functional role and the effect of SIRT2 in brain and
in a mouse model of a neurodegenerative disease have not been
shown.
Here, we report that SIRT2 deacetylates Foxo3a and activates
Bim in MPTP-treated (chronic regimen) mouse brains, inducing
apoptotic neuronal death. We also show that in MPP+-treated
SH-SY5Y cells, SIRT2 induces caspase-3 activated apoptotic cell
death. MPTP-induced nigrostriatal damage is reduced in SIRT2
knockout (KO) mice, indicating that SIRT2 deletion is protec-
tive against this treatment by preventing apoptosis. In addi-
tion, silencing SIRT2 reduces and overexpressing SIRT2 increases
caspase-3 activity in MPP+-treated SH-SY5Y cells. We show that
SIRT2 deacetylates Foxo3a, activates Bim, and induces apopto-
sis only in MPP+-treated cells and only in MPTP-injected mouse
brains. Therefore, we show here for the first time that inhibit-
ing SIRT2 in a mouse model of PD might be protective against
this disease and helpful in designing effective treatments in the
future.
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EXPERIMENTAL PROCEDURES
MOUSE STRAIN
All mice used were in congenic C57Bl/6. SIRT2 KO mice were
generated by the targeted insertion of a puromycin resistance
gene into exon 11 of the SIRT2 locus. The insertion introduces a
stop codon that should result in nonsense-mediated decay of the
SIRT2 mRNA (Bobrowska et al., 2012). All mice were housed at
controlled temperature (25◦C) and 12:12 h light-dark cycle. Mice
used were littermates or their parents were littermates.
PLASMIDS
The plasmids expressing mSIRT2 (13813) and Bim (8804)
were purchased from Addgene. The SIRT2-shRNA (RMM3981-
9579810) and Bim-shRNA (RHS4533-NM006538) plasmids were
purchased from Open Biosystems.
IMMUNOHISTOCHEMISTRY
Mice were perfused with 4% paraformaldehyde, cryoprotected,
and sectioned 30μm-thick. Eight to twelve sections per brain
were analyzed. Vectastain kit (Vector laboratories) was used
to perform TH-staining according to manufacturer’s directions
using TH antibody (EMD-Millipore). Nissl staining was per-
formed according to the manufacturer’s protocol (IHCWORLD).
TH-positive and Nissl-stained neurons in SNpc were counted by
the image analysis tool of NIS-Elements AR microscope software.
TH-positive striatal fibers were assessed by optical density. MPTP
i.p. (intraperitoneal injection)-administered mice that were used
for immunohistochemistry were 2 months old and received
MPTP (30mg kg−1 free baseMPTP) daily for six consecutive days
(Tatton and Kish, 1997; Jackson-Lewis and Przedborski, 2007).
WESTERN BLOTTING AND IMMUNOPRECIPITATION
Mouse brains were homogenized in RIPA buffer (50mM Tris-
HCl pH: 8.0, 1mM EDTA, 0.1% SDS, 150mM NaCl, 1%
NP40, 0.1% Sodium-deoxycholate) including Complete Protease
Inhibitor mixture (Roche), centrifuged, 100μg of the super-
natant was loaded onto 4–15% gradient SDS-PAGE gels and
immunoblotted with anti-SIRT2 (Cell signaling-12672, conc.
1:1000), Foxo3a (Abcam-ab47409, conc. 1:1000), Bim (Abcam-
ab7888, conc. 1:1000), actin (Millipore-MAB1501, conc. 1:5000),
Ac-K (Immunechem-ICP0380, conc.1:500) antibodies. Different
SIRT2 antibodies were tested for specificity and Cell Signaling-
12672 was used in the study (Supplementary Figure 1). Western
blotting experiments were performed with at least six mice
from each genotype and age and the representative blots are
shown. For western blotting using cell extracts, cells were har-
vested and extracted in RIPA buffer as explained above. The
immunoprecipitations were carried out by using Pierce Direct IP
Kit (Thermo Scientific) according to manufacturer’s directions.
MPTP-administered mice that were used for western blotting and
qPCR analysis were 3 months old and received 5 days of MPTP
treatment.
RNA ISOLATION AND ANALYSIS
Total RNA from mice brains or cells was isolated by using Trizol
(Invitrogen). For real time q-PCR analysis, cDNA was synthe-
sized from total RNA by RetroScript III reverse transcriptase
(Invitrogen) with random primers. The cDNAwas then subjected
to PCR analysis with gene specific primers in the presence
of SYBR green (Bio-Rad). Relative abundance of mRNA was
obtained by normalization to 18S levels. The primers used for Bim
qPCR are 5′-CACCATGGCA AGCAACCTTCTGATG-3′ (fwd)
and 5′-TCAATGCATTCTCCACACC-3′ (rev). The software used
to analyzed qPCR data is MxPro-Mx3000P v.4.10 Build 389,
Schema 85 Stratagene.
CELLS AND TRANSFECTION
SH-SY5Y cells (ATCC) were transfected using Effectene transfec-
tion reagent (Qiagen). MPP+ (Sigma) treatment was performed
according to Kalivendi et al. (2004).
CASPASE-3 ACTIVITY ASSAY
The Apo-Alert kit (Clontech) was used to measure caspase-3
activity according to manufacturer’s protocol.
STATISTICAL ANALYSIS
The analysis was performed using Two-way ANOVA. The type
of statistical analysis used is indicated in each figure legend.
Significant differences are demonstrated by single symbols (∗, #,
C, ∗ ∗ ∗) indicating p < 0.01, 0.001, 0.05. Error bars in figures
represent s.e.m.
RESULTS AND DISCUSSION
We wished to test whether the deletion of SIRT2 could rescue
MPTP-induced nigrostriatal damage by using SIRT2 KO mouse
model. SIRT2 KO animals show no differences in brain devel-
opment and gross anatomy. Gross histological examination of
the brain reveals normal morphology in SIRT2 KO mice (data
not shown, 10). MPTP is the most commonly used dopamin-
ergic neurotoxin that leads to reproducible nigrostriatal damage
after systemic administration. It is accepted as a pharmacological
model of Parkinson’s disease (Dauer and Przedborski, 2003). The
chronic MPTP regimen leads to neurodegeneration via apoptosis
(Dauer and Przedborski, 2003). We thus administered MPTP i.p.
(intraperitoneal injection) to SIRT2 KO and wild type (wt) mice
via chronic regimen (Tatton and Kish, 1997; Jackson-Lewis and
Przedborski, 2007). Nigrostriatal damage caused by the chronic
regimen ofMPTP is the death of dopaminergic neurons via apop-
tosis. The number of dopaminergic neurons in the substantia
nigra pars compacta (SNpc) and the striatal fibers were assessed
by TH (tyrosine-hydroxylase) immunoreactivity.
We observed amarked reduction in the number of TH-positive
neurons in MPTP-treated wt or SIRT2 KO mice compared to
saline-treated wt or SIRT2 KO mice (controls) (Figure 1A, n =
4–5 for each group). However, the number of TH-positive neu-
rons in MPTP-treated SIRT2 KO mice was significantly higher
than MPTP-treated wt mice. This result indicates that deletion
of SIRT2 leads to a decrease in the nigrostriatal damage caused by
MPTP (Figure 1A). We also analyzed the number of neurons in
substantia nigra by Nissl staining and observed that it was reduced
after MPTP treatment in wt mice (Figure 1B). However, the
number of neurons in MPTP-treated SIRT2 KO mice was signifi-
cantly higher than MPTP-treated wt mice (Figure 1B). Similarly,
the density of TH-positive striatal fibers was reduced after
MPTP-treatment in wt mice (Figure 1C). However, the density
of TH-positive striatal fibers in MPTP-dosed SIRT2 KO mice was
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FIGURE 1 | Deletion of SIRT2 reduces the MPTP-induced nigrostriatal
damage in mouse brains. (A) The left panel shows immunostaining of
TH-positive neurons in the substantia nigra pars compacta (SNpc) in saline- or
MPTP-dosed wt or SIRT2 KO mice. Scale bar represents 100μM. The
quantification on the right shows the number of SNpc neurons counted by
the image analysis tool of NIS-Elements AR microscope software. Bars
represent s.e.m (n = 4–5). Statistical analyses were carried out using
Two-Way ANOVA. ∗∗∗p < 0.001, MPTP vs. saline groups; ∗p < 0.05, SIRT2
KO-MPTP vs. wt-MPTP. (B) The left panel shows the Nissl staining of the
neurons in SNpc of saline- or MPTP-dosed mice. Scale bar represents
100μM. The quantification on the right shows the number of Nissl-stained
neurons in SNpc counted by the image analysis tool of NIS-Elements AR
microscope software. Bars represent s.e.m (n = 4–5). Statistical analyses
were carried out using Two-Way ANOVA. ∗∗∗p < 0.001, MPTP vs. saline
groups; ∗p < 0.05, SIRT2 KO-MPTP vs. wt-MPTP. (C) The left panel shows
the TH-positive striatal fibers in saline- or MPTP-dosed wt or SIRT2 KO mice.
Quantification on the right shows the loss of striatal fibers in MPTP-dosed
mice assessed by optical density (n = 4–5). Statistical analyses were carried
out using Two-Way ANOVA. ∗∗∗p < 0.001, MPTP vs. saline groups; ∗p < 0.05,
SIRT2 KO-MPTP vs. wt-MPTP.
higher compared to the MPTP-dosed wt mice (Figure 1C). These
data demonstrate that the deletion of SIRT2 prevents the loss of
TH-positive neurons of SNpc and the striatal fibers after MPTP
treatment.
Since chronic administration of MPTP induces apoptotic neu-
ronal death inmouse brains, we wanted to analyze whether silenc-
ing or overexpressing SIRT2 affects the MPP+-induced apoptosis
in SH-SY5Y (neuroblastoma) cells. Therefore, we overexpressed
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FIGURE 2 | SIRT2 deacetylates Foxo3a, increases Bim levels and leads to
apoptosis in MPP+-treated cells. (A) MPP+ treatment increases caspase-3
activity in SH-SY5Y (neuroblastoma) cells. Caspase-3 activity was determined
from the supernatants of SH-SY5Y cell lysates after treatment with MPP+ for
the indicated times. Bars represent s.e.m of three independent experiments.
Statistical analyses were carried out using Two-way ANOVA. ∗p < 0.01, 8 h
vs. 0 h; #p < 0.01, 12 h vs. 8 h; εp < 0.01, 16 h vs. 12 h. (B) Overexpression of
SIRT2 increases and silencing SIRT2 decreases the caspase-3 activity that is
elevated after MPP+ treatment. The graph shows the caspase-3 activity in
the supernatants of SH-SY5Y cell lysates where SIRT2 is overexpressed
(+SIRT2) or silenced (SIRT2-shRNA) without (no MPP+) or with MPP+
treatment for 16 h. Bars represent s.e.m of three independent experiments.
Statistical analyses were carried out using Two-Way ANOVA. ∗p < 0.01,
vector with MPP+ vs. vector no MPP+; #p < 0.01, SIRT2-shRNA with MPP+
vs. vector with MPP+; εp < 0.01, +SIRT2 with MPP+ vs. vector with MPP+.
(C) Relative protein levels of SIRT2 are increased as a result of transfection
with SIRT2 plasmid and reduced as a result of silencing with SIRT2-shRNA
plasmid (total 48 h). The expressions were also measured after 64 h (48 h
transfection + 16 h MPP+ treatment). The panel shows a representative
western blot of SIRT2 levels from the lysates of SH-SY5Y cells transfected
with SIRT2 (+SIRT2), or SIRT2-shRNA (SIRT2-shRNA) plasmids or empty
vector (wt) with anti-SIRT2 antibody. Actin serves as a loading control. (D)
SIRT2 deacetylates Foxo3a after MPP+ treatment. The panel shows the
lysates of SH-SY5Y cells without MPP+ treatment transfected with SIRT2
(+SIRT2) or SIRT2-shRNA (SIRT2-shRNA) or empty vector (vector)
immunoprecipitated with Foxo3a antibody or NRS (Normal Rabbit Serum) and
blotted with anti-Foxo3a and anti-acetylated lysine (Ac-K) antibodies without
or with 16 h of MPP+ treatment. Quantification of the acetylated bands was
carried out by densitometry using the NIH ImageJ program and is shown
below the gel. (E) Relative Bim RNA levels quantified by qPCR from SH-SY5Y
cell extracts transfected with vector, SIRT2 or SIRT2-shRNA plasmid with or
(Continued)
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FIGURE 2 | Continued
without MPP+ treatment. Bars represent s.e.m of three independent
experiments. Statistical analyses were carried out using Two-Way ANOVA.
∗p < 0.01, vector with MPP+ vs. vector no MPP+; #p < 0.01, SIRT2-shRNA
with MPP+ vs. vector with MPP+; εp < 0.01, +SIRT2 with MPP+ vs. vector
with MPP+. (F) Western blotting of Bim protein extracted from the lysates of
SH-SY5Y cells transfected with SIRT2 (+SIRT2) or SIRT2-shRNA
(SIRT2-shRNA) or empty vector (vector) with or without MPP+ treatment.
Quantification was carried out by densitometry using the NIH ImageJ
program and is shown on the right. Three independent experiments were
performed. Representative blot is shown. Statistical analyses were carried
out using Two-Way ANOVA. ∗p < 0.01, vector with 16 h MPP+ vs. vector no
MPP+; #p < 0.01, SIRT2-shRNA with 16 h MPP+ vs. vector with 16 h MPP+;
εp < 0.01, +SIRT2 with MPP+ vs. vector with 16 h MPP+.
or silenced SIRT2 in SH-SY5Y cells and assayed apoptosis. We
used caspase-3 activity as a measure of MPP+-induced apop-
tosis. Caspase-3 is an active cell-death protease involved in the
execution phase of apoptosis, where cells undergo morpholog-
ical changes such as DNA fragmentation, chromatin condensa-
tion, and apoptotic body formation (Porter and Jänicke, 1999).
Caspase-3 is activated in response to treatment with pharmaco-
logical agents such as MPP+. SH-SY5Y cells were treated with
media alone or MPP+ to a final concentration of 500μM for
different time intervals (2, 4, 6, 8, 12, 16 h) (Kalivendi et al.,
2004). Caspase-3 activity in cells treated 16 h with medium alone
was comparable to the activity in untreated cells (0 h, Figure 2A).
MPP+ treatment increased caspase-3 activity only after 8 h of
treatment, reaching the highest levels after 16 h (Figure 2A).
To test the effect of SIRT2 on MPP+-induced apoptosis,
SH-SY5Y cells were transfected with empty vector (wt), SIRT2
plasmid to overexpress SIRT2, or SIRT2-shRNA plasmid to
silence SIRT2 (See Experimental Procedures). We first overex-
pressed or silenced SIRT2 in cells and checked SIRT2 levels both
after transfection (48 h) and also after 16 h MPP+ treatment
(totally 64 h) and confirmed overexpression or silencing in both
cases (Figure 2C). 48 h after transfection, cells were treated with
MPP+ for 16 h, and then caspase-3 activity was analyzed. SIRT2
overexpression or silencing had no effect on caspase-3 activity
in the absence of MPP+ treatment (Figure 2B). After 16 h of
MPP+ treatment, caspase-3 activity was increased in wt cells
(vector, Figure 2B). SIRT2 silencing decreased caspase-3 activ-
ity to baseline while overexpressing SIRT2 increased caspase-3
activity. Scrambled shRNA did not have any effect on caspase-
3 activity. This result indicates that silencing SIRT2 prevents
MPP+-induced apoptosis in SH-SY5Y cells.
SIRT2 was shown to promote cell death when cells are under
severe stress by activating Bim, a pro-apoptotic factor (Wang
et al., 2007). It was shown that, in cell culture, SIRT2 deacetylates
Foxo3a. Since Bim is a pro-apoptotic factor that is one of Foxo3a’s
target genes, we analyzed whether SIRT2 deacetylates Foxo3a in
SH-SY5Y cells and elevates Bim expression. In order to measure
the acetylation level of Foxo3a in MPP+-treated cells with SIRT2
overexpression or silencing, we immunoprecipitated Foxo3a from
the extracts of cells transfected with control vector, SIRT2 plasmid
or SIRT2 shRNA plasmid using Foxo3a antibody. We then blot-
ted the eluates with acetylated lysine (Ac-K) antibody to detect
the acetylation of Foxo3a (Figure 2D). The acetylation levels of
Foxo3a were not changed in the absence of MPP+ treatment (no
MPP+) where SIRT2 was silenced or overexpressed (Figure 2D,
left panel). After 16 h MPP+ treatment, we observed that the
acetylation levels of Foxo3a were decreased in SIRT2 overexpress-
ing cells and increased in SIRT2-silenced cells compared to empty
vector. This result demonstrates that SIRT2 deacetylates Foxo3a
in SH-SY5Y cells only after MPP+ treatment (Figure 2D, right
panel).
We then tested whether the deacetylation of Foxo3a by SIRT2
elevates the expression level of Bim in cells. We first analyzed the
RNA levels of Bim (Figure 2E). After 16 h of MPP+ treatment,
Bim RNA levels were increased with overexpressing SIRT2 and
decreased with silencing SIRT2. There was no difference in Bim
RNA levels with SIRT2 overexpression or silencing in the absence
of MPP+ treatment (Figure 2E). The protein levels of Bim in cells
were consistent with its RNA levels (Figure 2F).
We then analyzed whether SIRT2 deacetylates Foxo3a and
increases Bim levels in saline or MPTP-injected mouse brains. We
observed that acetylation levels of Foxo3a increase only in MPTP-
treated SIRT2 KO mouse brains compared to wt brains, indicat-
ing that SIRT2 deacetylates Foxo3a only after MPTP treatment
(Figure 3A). To investigate whether Bim expression increases as
a result of Foxo3a deacetylation, we analyzed the RNA levels of
Bim in saline or MPTP-treated wt or SIRT2 KO mouse brains
(Figure 3B) (n = 6). We observed that there is no difference in
Bim RNA levels in saline treated wt or SIRT2 KO mice. However,
Bim RNA levels increase inMPTP-treated wtmice brains, and not
in MPTP-treated SIRT2 KO mice (Figure 3B). Bim protein levels
were also consistent with RNA levels in vivo, increasing only in
MPTP-treated wt mouse brains (Figure 3C) (n = 6). These data
show that SIRT2 deacetylates Foxo3a and increases Bim levels
only after MPTP treatment in mouse brains.
In order to confirm the mechanism that the increase in apop-
tosis after MPTP treatment is through the increase in Foxo3a
deacetylation and Bim expression, we assayed caspase-3 activity
in MPP+-treated SH-SY5Y cells where we manipulated the levels
of SIRT2 and Bim (Figure 3E). Figure 3D indicates the protein
levels of Bim after its silencing or overexpression in cells. Caspase-
3 activity was increased when SIRT2 was overexpressed, and
decreased when SIRT2 was silenced (Figure 3E). Overexpressing
Bim increased caspase-3 activity to similar levels as in SIRT2 over-
expression. In addition, silencing Bim decreased caspase-3 activ-
ity to similar levels as in SIRT2 silencing. Importantly, when we
overexpress SIRT2 in MPP+-treated Bim-silenced cells, Caspase-
3 activity was at the levels of wt cells (vector) and not as high as in
the case of SIRT2 overexpression. This indicates that elevated Bim
expression is the main cause of apoptosis. In addition, caspase-3
activity in cells expressing both SIRT2-shRNA and Bim-shRNA
was not significantly lower than in cells expressing SIRT2-shRNA
or Bim-shRNA alone indicating that the effect is not additive. The
latter experiment suggests that SIRT2 and Foxo3a function in the
same pathway to elevate caspase-3 activity. Scrambled-shRNAs
did not have any effect on the caspase-3 activity (Figure 3E).
In addition, the graph on the right shows that caspase-3 activ-
ity increases as a result of Bim overexpression in cells without
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FIGURE 3 | SIRT2 deacetylates Foxo3a, increases Bim levels and leads to
apoptosis in MPTP-treated mouse brains. (A) SIRT2 deacetylates Foxo3a
in MPTP-injected mouse brains. The lysates from wt or SIRT2 KO mouse
brains were immunoprecipitated with Foxo3a antibody or NRS (Normal Rabbit
Serum) and blotted with anti-Foxo3a or anti-acetylated lysine (Ac-K) antibodies
in saline or MPTP-injected mouse brains. Quantification of acetylated bands
was carried out by densitometry using the NIH ImageJ program and is shown
below the gel. Representative blots are shown. (B) Bim RNA levels quantified
from whole brains of mice by qPCR. n = 6 for each indicated group.
Statistical analyses were carried out using Two-Way ANOVA. ∗p < 0.01,
wt-MPTP vs. wt-saline. (C) Western blotting of Bim protein extracted from
whole brains of saline or MPTP-treated wt or SIRT2 KO mouse brains. n = 6
for each group. Actin serves as loading control. Representative immunoblot is
shown. Quantification of the relative Bim protein levels is shown on the right.
Statistical analyses were carried out using Two-Way ANOVA. ∗p < 0.01,
wt-MPTP vs. wt-saline. (D) Western blotting of Bim levels from the lysates of
SH-SY5Y cells that are transfected with Bim or Bim-shRNA plasmids. Actin
serves as a loading control. (E) Caspase-3 activity of SH-SY5Y cells
transfected with SIRT2, SIRT2-shRNA, Bim or Bim-shRNA plasmids and
treated with 16 h MPP+. The graph on the right shows Caspase-3 activity of
SH-SY5Y cells after Bim overexpression without MPP+ treatment. (F) Left
panel shows the western blotting of SIRT2 protein extracted from wt or
MPP+-treated SH-SY5Y cells. Three independent experiments were
performed. Right panel shows the western blotting of SIRT2 protein
extracted from whole brains of saline or MPTP-treated wt mice. n = 6 for
each group. Actin serves as loading control. Representative immunoblots are
shown. Quantifications of the relative SIRT2 protein levels are shown below.
Statistical analyses were carried out using Two-Way ANOVA.
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MPP+ treatment (Figure 3E). We have also analyzed whether the
expression level of SIRT2 is upregulated in MPP+-treated cells or
MPTP-treated mice by western blotting (Figure 3F). We did not
observe any change in SIRT2 protein levels in MPP+-treated cells
compared to control cells or in MPTP-injected mice compared to
control mice, indicating that the increase in Bim expression levels
is not caused by the increase in SIRT2 expression (Figure 3F).
These data show that SIRT2 leads to neurodegeneration in
MPTP-injected mice and MPP+-treated cells by deacetylating
Foxo3a and increasing Bim levels, therefore leading to apoptosis.
We also show that deletion of SIRT2 prevents neuronal death in
MPTP-treated mice. Similarly, silencing SIRT2 in MPP+-treated
cells also inhibits apoptosis. The results shown here are also con-
sistent with the fact that sirtuins are stress-response genes. In this
study, SIRT2 is shown to deacetylate Foxo3a and increase Bim
levels only after MPP+-treatment in cells or MPTP-injection in
mice. Similarly, in a previous study (Donmez et al., 2012), SIRT1
was shown to deacetylate HSF1 and increase Hsp70 levels only
after heat shock in cells or only in the brains of Parkinson’s dis-
ease mouse model (A53T alpha-synuclein). These studies show
that SIRT1 and SIRT2 are activated as a result of stress condi-
tions and turn on their target pathways. Therefore, in the future,
designing SIRT2 inhibitors that become activated as a result of
the disease condition might be useful in developing treatments
for Parkinson’s disease.
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REFERENCES
Bobrowska, A., Donmez, G., Weiss, A., Guarente, L., and Bates, G. (2012). SIRT2
ablation has no effect in tubulin acetylation in brain, cholesterol biosynthe-
sis or the progression of Huntington’s disease phenotypes in vivo. PLoS ONE
7:e34805. doi: 10.1371/journal.pone.0034805
Dauer, W., and Przedborski, S. (2003). Parkinson’s disease: mechanisms and
models. Neuron 39, 889–909. doi: 10.1016/S0896-6273(03)00568-3
Donmez, G. (2012). The neurobiology of sirtuins and their role in neurodegenera-
tion. Trends Pharmacol. Sci. 33, 494–501. doi: 10.1016/j.tips.2012.05.007
Donmez, G., Arun, A., Chung, C. Y., McLean, P. J., Lindquist, S., and Guarente,
L. (2012). SIRT1 protects against α-synuclein aggregation by activating molec-
ular chaperones. J. Neurosci. 32, 124–132. doi: 10.1523/JNEUROSCI.3442-
11.2012
Donmez, G., and Guarente, L. (2010). Aging and disease: connections to sirtuins.
Aging Cell. 9, 285–290. doi: 10.1111/j.1474-9726.2010.00548.x
Donmez, G., Wang, D., Cohen, D. E., and Guarente, L. (2010). SIRT1 suppresses
beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell
142, 320–332. doi: 10.1016/j.cell.2010.06.020
Jackson-Lewis, V., and Przedborski, S. (2007). Protocol for the MPTP mouse
model of Parkinson’s disease. Nat. Protoc. 2, 141–151. doi: 10.1038/nprot.
2006.342
Kalivendi, S. V., Cunningham, S., Kotamraju, S., Joseph, J., Hillard, C. J., and
Kalyanaraman, B. (2004). Alpha-synuclein up-regulation and aggregation dur-
ing MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transfer-
rin receptor iron and hydrogen peroxide. J. Biol. Chem. 279, 15240–15247. doi:
10.1074/jbc.M312497200
Luthi-Carter, R., Taylor, D. M., Pallos, J., Lambert, E., Amore, A., Parker,
A., et al. (2010). SIRT2 inhibition achieves neuroprotection by decreas-
ing sterol biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 107, 7927–7932. doi:
10.1073/pnas.1002924107
Maxwell, M. M., Tomkinson, E. M., Nobles, J., Wizeman, J. W., Amore, A. M.,
Quinti, L., et al. (2011). The Sirtuin 2 microtubule deacetylase is an abun-
dant neuronal protein that accumulates in the aging CNS. Hum. Mol. Genet.
20, 3986–3996. doi: 10.1093/hmg/ddr326
Outerio, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K.
E., Amore, A. M., et al. (2007). Sirtuin 2 inhibitors rescue alpha-synuclein-
mediated toxicity in models of Parkinson’s disease. Science 317, 516–519. doi:
10.1126/science.1143780
Porter, A. G., and Jänicke, R. U. (1999). Emerging roles of caspase-3 in apoptosis.
Cell Death Differ. 6, 99–104. doi: 10.1038/sj.cdd.4400476
Tatton, N. A., and Kish, S. J. (1997). In situ detection of apoptotic nuclei in the
substantia nigra compacta of 1-meythl-4-phenyl-1,2,3,6-tetrahydropyridine-
treated mice using terminal deoxynucleotidyl transferase labeling and acri-
dine orange staining. Neurosciences 77, 1037–1048. doi: 10.1016/S0306-
4522(96)00545-3
Wang, F., Nguyen, M., Qin, F. X., and Tong, Q. (2007). SIRT2 deacetylates FOXO3a
in response to oxidative stress and caloric restriction. Aging Cell 6, 505–514.
doi: 10.1111/j.1474-9726.2007.00304.x
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 23 April 2014; accepted: 09 July 2014; published online: 11 August 2014.
Citation: Liu L, Arun A, Ellis L, Peritore C and Donmez G (2014) SIRT2 enhances 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage
via apoptotic pathway. Front. Aging Neurosci. 6:184. doi: 10.3389/fnagi.2014.00184
This article was submitted to the journal Frontiers in Aging Neuroscience.
Copyright © 2014 Liu, Arun, Ellis, Peritore and Donmez. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, pro-
vided the original author(s) or licensor are credited and that the original publi-
cation in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Aging Neuroscience www.frontiersin.org August 2014 | Volume 6 | Article 184 | 7
